New Zealand markets closed

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
5.88+0.52 (+9.70%)
At close: 04:00PM EDT
5.88 0.00 (0.00%)
Pre-market: 04:43AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 326.78M
Enterprise value 48.68M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.59
Price/book (mrq)0.39
Enterprise value/revenue 0.26
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.07
52-week change 3-92.72%
S&P500 52-week change 323.01%
52-week high 383.20
52-week low 35.26
50-day moving average 310.76
200-day moving average 335.76

Share statistics

Avg vol (3-month) 31.62M
Avg vol (10-day) 31.68M
Shares outstanding 543.1M
Implied shares outstanding 655.58M
Float 831.44M
% held by insiders 16.43%
% held by institutions 163.84%
Shares short (15 Aug 2024) 43.84M
Short ratio (15 Aug 2024) 43.33
Short % of float (15 Aug 2024) 412.30%
Short % of shares outstanding (15 Aug 2024) 46.90%
Shares short (prior month 15 Jul 2024) 42.43M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:40
Last split date 320 Aug 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-274.48%

Management effectiveness

Return on assets (ttm)-22.30%
Return on equity (ttm)-76.83%

Income statement

Revenue (ttm)184.34M
Revenue per share (ttm)3.69
Quarterly revenue growth (yoy)-30.20%
Gross profit (ttm)N/A
EBITDA -633.69M
Net income avi to common (ttm)-897.68M
Diluted EPS (ttm)-18.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)730.37M
Total cash per share (mrq)14.05
Total debt (mrq)452.26M
Total debt/equity (mrq)54.29%
Current ratio (mrq)4.72
Book value per share (mrq)16.03

Cash flow statement

Operating cash flow (ttm)-305.03M
Levered free cash flow (ttm)-167.4M